Chris MacDonald

Chris MacDonald

InvestorPlace Contributor

About Chris MacDonald

Chris MacDonald is an MBA (finance) graduate with extensive experience covering small-, mid- and large-cap companies in the U.S. and Canadian markets. Chris is interesting in uncovering long-term and deep-value opportunities for investors based on principles from the Graham-Buffett school of thought, and looks forward to bringing investors a unique fundamental-based perspective on opportunities available in today’s challenging investing environment.

His experience as a financial analyst in the past, coupled with his fervor for finding undervalued growth opportunities, contribute to his conservative, long-term investing perspective.

Recent Articles

3 No-Brainer Cryptos to Buy If You Have Money to Invest

By Chris MacDonald, InvestorPlace Contributor

These three no-brainer cryptos to buy are tokens which have been beaten up by the market, but which provide intriguing upside potential.

bioAffinity (BIAF) Stock Pops 100% in Red-Hot IPO

By Chris MacDonald, InvestorPlace Contributor

Today, investors in bioAffinity and BIAF stock saw major gains as this stock surged more than 100% at one point during today's session.

Terra Classic Price Predictions: Where Will LUNC Go After Major Rally?

By Chris MacDonald, InvestorPlace Contributor

Investors interested in Terra Classic price predictions have a lot to be excited about this week, with token burns making headlines.

3 EV Stocks to Buy Now at a Discount

By Chris MacDonald, InvestorPlace Contributor

Here are three top EV stocks every investor may want to consider as long-term bets, despite the recent market downturn of late.

Why Is Bausch Health (BHC) Up 17% Today?

By Chris MacDonald, InvestorPlace Contributor

Today, investors in Bausch Health and BHC stock are cheering an announced $4 billion debt swap, which will push out the company's obligations.

Load More